Clinical Trial Update: Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting on the efficacy of 0.05% cyclosporin eye drops in a patient with Stevens-Johnson syndrome and chronic dry eye; the trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Stevens-johnson Syndrome

Drugs mentioned

• Cyclosporin Eye Drop 0.05% (cyclosporine ophthalmic emulsion)

Snippet

Sponsor: Mahidol University | Conditions: Stevens-Johnson Syndrome | Phase 4 | Status: COMPLETED